Glycemic Control, Glucose-Lowering Medication Use, and Utilization among Older Patients with Diabetes

被引：0
|
作者：
Kuntz, Jennifer L.
Nichols, Gregory A.
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
301-OR
引用
收藏
页码：A79 / A80
页数：2
相关论文
共 50 条
  • [41] Mechanisms of glucose-lowering effect by rosiglitazone in patients with type 2 diabetes
    Miyazaki, Y
    Matsuda, M
    Mahankali, A
    Mahankali, S
    Cusi, K
    Mandarino, L
    Defronzo, R
    DIABETES, 2001, 50 : A126 - A127
  • [42] Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease
    SHamkhalova, M. S. H.
    YArek-Martynova, I. Y. A.
    Trubitsyna, N. P.
    SHestakova, M., V
    DIABETES MELLITUS, 2013, 16 (03): : 97 - 102
  • [43] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Prattichizzo, Francesco
    La Sala, Lucia
    Ryden, Lars
    Marx, Nikolaus
    Ferrini, Marc
    Valensi, Paul
    Ceriello, Antonio
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
  • [44] Treatment burden and perceptions of glucose-lowering therapy among people living with diabetes
    Gonzalez-Saldivar, Gerardo
    Manuel Millan-Alanis, Juan
    Gerardo Gonzalez-Gonzalez, Jose
    Sanchez-Gomez, Raymundo A.
    Obeso-Fernandez, Javier
    McCoy, Rozalina G.
    Maraka, Spyridoula
    Brito, Juan P.
    Ospina, Naykky Singh
    Oyervides-Fuentes, Stephie
    Rodriguez-Gutierrez, Rene
    PRIMARY CARE DIABETES, 2022, 16 (04) : 568 - 573
  • [45] Evaluating glucose-lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial
    Sinclair, Alan J.
    Heller, Simon R.
    Pratley, Richard E.
    Duan, Ran
    Heine, Robert J.
    Festa, Andreas
    Kiljanski, Jacek
    DIABETES OBESITY & METABOLISM, 2020, 22 (08): : 1231 - 1242
  • [46] Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities
    Doucet, Jean
    Gourdy, Pierre
    Meyer, Laurent
    Benabdelmoumene, Nabil
    Bourdel-Marchasson, Isabelle
    CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 1687 - 1703
  • [47] Factors Influencing the Choice of Glucose-Lowering Medications Among Physicians Treating Patients With Type 2 Diabetes
    AlSofiani, Mohammed E.
    AlHalees, Danah Z.
    Aljebreen, Joud A.
    Abu Dahesh, Joud A.
    Bamogaddam, Ghada S.
    AlBraithen, Ghaida M.
    Jammah, Anwar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [48] Use of glucose-lowering drugs in Hungary between 2008 and 2017: the increasing use of novel glucose-lowering drug groups
    Csatordai, M.
    Benko, R.
    Matuz, M.
    Bor, A.
    Lengyel, C.
    Doro, P.
    DIABETIC MEDICINE, 2019, 36 (12) : 1612 - 1620
  • [49] Less timely initiation of glucose-lowering medication among younger and male patients with diabetes and similar initiation of blood pressure-lowering medication across age and sex: Trends between 2015 and 2020
    Denig, Petra
    Ambroz, Martina
    de Vries, Sieta
    Hoogenberg, Klaas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 181 - 182
  • [50] Meta-Analysis on the Efficacy of Novel Glucose-Lowering Agents in Older Patients With Type 2 Diabetes Mellitus
    Ahmed, Aymen
    Imran, Laiba
    Naeem, Unaiza
    Jawed, Areesha
    Jawed, Aleeza
    Khan, Zayeema
    Arshad, Abdul Rehman
    Arshad, Muhammad Sameer
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 187 : 127 - 130
12345